Novavax

Novavax files for emergency use approval of COVID-19 vaccine with WHO

Novavax will make further submissions to enable vaccine supply from additional manufacturing sites in Novavax' global supply chain.

Novavax, SII apply to WHO for emergency use listing of COVID-19 vaccines

The application to WHO is based on the companies' previous regulatory submission to the Drugs Controller General of India (DCGI), Novavax Inc said in a statement.

Cuba becomes first country in world to begin vaccinating toddlers against COVID-19

The Abdala and Soberana vaccines are being given to children aged between 2-11

European Commission inks new pact with Novavax for potential COVID-19 vaccine

Under the new contract, the member states will be able to buy up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses over the course of 2021, 2022, and 2023

SII manufacturing first batch of Novavax's COVID-19 vaccine Covovax, says Adar Poonawalla

In March, Poonawalla had said that the clinical trials of the Covovax vaccine have begun in India and the company hopes to launch it by September this year

COVID-19 updates: Punjab, Jharkhand ease curbs; Central panel confirms first death due to vaccination

The National AEFI Committee however said that all benefits of vaccination are overwhelmingly greater than the small risk of harm

Novavax vaccine leaves Covishield, Covaxin way behind with 90.4% overall efficacy

Likely to be priced at Rs 1,114 per dose in India, Novavax vaccine will be a two-dose jab like the other vaccines

COVID-19 updates: Bengal, Uttarakhand extend curbs with some relaxations; India logs 70,421 new cases

Meanwhile, the Archaeological Survey of India issued an order stating that all centrally protected monuments, museums and sites will reopen from 16 June

Novavax claims large study in US and Mexico finds its COVID-19 vaccine about 90% effective

The vaccine was similarly effective against several variants including the one first detected in the UK, and in high-risk populations

Serum institute seeks permission to manufacture Sputnik V vaccine in India

SII said it will be able to manufacture and supply 10 crore Covishield doses in June while also manufacturing Novavax.